Paladin Advisory Group, LLC Merck & Co., Inc. Call Options Transaction History

Paladin Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 11, 2023	SELL	$87.44 - $112.11 $10,755 - $13,789	-123 Reduced 1.06%	11,504 $0
Q3 2022 Oct 07, 2022	BUY	$84.53 - $94.96 $5,748 - $6,457	68 Added 0.59%	11,627 $1 Million
Q2 2022 Jul 06, 2022	SELL	$83.49 - $94.64 $3,840 - $4,353	-46 Reduced 0.4%	11,559 $1.05 Million
Q4 2021 Jan 11, 2022	BUY	$72.28 - $90.54 $838,809 - $1.05 Million	11,605 New	11,605 $889,000

3,828

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Paladin Advisory Group, LLC with notifications on news.